Telix Pharmaceuticals Statistics
Total Valuation
TLX has a market cap or net worth of $3.21 billion. The enterprise value is $3.43 billion.
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
TLX has 338.40 million shares outstanding. The number of shares has decreased by -37.99% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 338.40M |
| Shares Change (YoY) | -37.99% |
| Shares Change (QoQ) | -4.06% |
| Owned by Insiders (%) | 14.85% |
| Owned by Institutions (%) | 33.26% |
| Float | 275.43M |
Valuation Ratios
The trailing PE ratio is 226.78 and the forward PE ratio is 29.91.
| PE Ratio | 226.78 |
| Forward PE | 29.91 |
| PS Ratio | 4.84 |
| Forward PS | n/a |
| PB Ratio | 7.62 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 333.56 |
| P/OCF Ratio | 142.06 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 94.12, with an EV/FCF ratio of 355.57.
| EV / Earnings | 315.97 |
| EV / Sales | 5.16 |
| EV / EBITDA | 94.12 |
| EV / EBIT | 121.95 |
| EV / FCF | 355.57 |
Financial Position
The company has a current ratio of 1.33, with a Debt / Equity ratio of 0.99.
| Current Ratio | 1.33 |
| Quick Ratio | 1.11 |
| Debt / Equity | 0.99 |
| Debt / EBITDA | 10.42 |
| Debt / FCF | 43.40 |
| Interest Coverage | 2.64 |
Financial Efficiency
Return on equity (ROE) is 3.14% and return on invested capital (ROIC) is 3.12%.
| Return on Equity (ROE) | 3.14% |
| Return on Assets (ROA) | 2.08% |
| Return on Invested Capital (ROIC) | 3.12% |
| Return on Capital Employed (ROCE) | 3.15% |
| Revenue Per Employee | $1.57M |
| Profits Per Employee | $25,637 |
| Employee Count | 234 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 10.97 |
Taxes
| Income Tax | -1.80M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 2.38 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 12.95 |
| 200-Day Moving Average | 15.90 |
| Relative Strength Index (RSI) | 36.61 |
| Average Volume (20 Days) | 255,610 |
Short Selling Information
The latest short interest is 19,552, so 0.01% of the outstanding shares have been sold short.
| Short Interest | 19,552 |
| Short Previous Month | 48,849 |
| Short % of Shares Out | 0.01% |
| Short % of Float | 0.01% |
| Short Ratio (days to cover) | 1.61 |
Income Statement
In the last 12 months, TLX had revenue of $664.23 million and earned $10.84 million in profits. Earnings per share was $0.04.
| Revenue | 664.23M |
| Gross Profit | 358.28M |
| Operating Income | 28.10M |
| Pretax Income | 20.66M |
| Net Income | 10.84M |
| EBITDA | 36.41M |
| EBIT | 28.10M |
| Earnings Per Share (EPS) | $0.04 |
Full Income StatementBalance Sheet
The company has $207.16 million in cash and $418.25 million in debt, giving a net cash position of -$211.10 million or -$0.62 per share.
| Cash & Cash Equivalents | 207.16M |
| Total Debt | 418.25M |
| Net Cash | -211.10M |
| Net Cash Per Share | -$0.62 |
| Equity (Book Value) | 421.94M |
| Book Value Per Share | 1.25 |
| Working Capital | 99.43M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $22.63 million and capital expenditures -$12.99 million, giving a free cash flow of $9.64 million.
| Operating Cash Flow | 22.63M |
| Capital Expenditures | -12.99M |
| Free Cash Flow | 9.64M |
| FCF Per Share | $0.03 |
Full Cash Flow StatementMargins
Gross margin is 53.94%, with operating and profit margins of 4.23% and 1.63%.
| Gross Margin | 53.94% |
| Operating Margin | 4.23% |
| Pretax Margin | 1.36% |
| Profit Margin | 1.63% |
| EBITDA Margin | 5.48% |
| EBIT Margin | 4.23% |
| FCF Margin | 1.45% |
Dividends & Yields
TLX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 37.99% |
| Shareholder Yield | 37.99% |
| Earnings Yield | 0.34% |
| FCF Yield | 0.30% |
Analyst Forecast
The average price target for TLX is $21.33, which is 120.35% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $21.33 |
| Price Target Difference | 120.35% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TLX has an Altman Z-Score of 4.57 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.57 |
| Piotroski F-Score | 5 |
